381 related articles for article (PubMed ID: 29523488)
1. Evaluation and Management of Hypoactive Sexual Desire Disorder.
Clayton AH; Kingsberg SA; Goldstein I
Sex Med; 2018 Jun; 6(2):59-74. PubMed ID: 29523488
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.
Croft HA
J Sex Med; 2017 Dec; 14(12):1575-1584. PubMed ID: 29198512
[TBL] [Abstract][Full Text] [Related]
3. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
Simon JA; Kingsberg SA; Goldstein I; Kim NN; Hakim B; Millheiser L
Sex Med Rev; 2019 Oct; 7(4):575-586. PubMed ID: 31196764
[TBL] [Abstract][Full Text] [Related]
4. Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
Kingsberg SA; Simon JA
J Womens Health (Larchmt); 2020 Aug; 29(8):1101-1112. PubMed ID: 32460605
[TBL] [Abstract][Full Text] [Related]
5. New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.
Jayne CJ; Heard MJ; Zubair S; Johnson DL
Int J Womens Health; 2017; 9():171-178. PubMed ID: 28442935
[TBL] [Abstract][Full Text] [Related]
6. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.
Clayton AH; Goldstein I; Kim NN; Althof SE; Faubion SS; Faught BM; Parish SJ; Simon JA; Vignozzi L; Christiansen K; Davis SR; Freedman MA; Kingsberg SA; Kirana PS; Larkin L; McCabe M; Sadovsky R
Mayo Clin Proc; 2018 Apr; 93(4):467-487. PubMed ID: 29545008
[TBL] [Abstract][Full Text] [Related]
7. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
8. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I; Kim NN; Clayton AH; DeRogatis LR; Giraldi A; Parish SJ; Pfaus J; Simon JA; Kingsberg SA; Meston C; Stahl SM; Wallen K; Worsley R
Mayo Clin Proc; 2017 Jan; 92(1):114-128. PubMed ID: 27916394
[TBL] [Abstract][Full Text] [Related]
9. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
Anderson R; Moffatt CE
J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
[TBL] [Abstract][Full Text] [Related]
10. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
Pfaus JG; Sadiq A; Spana C; Clayton AH
CNS Spectr; 2022 Jun; 27(3):281-289. PubMed ID: 33455598
[TBL] [Abstract][Full Text] [Related]
11. The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.
Kingsberg SA; Clayton AH; Pfaus JG
CNS Drugs; 2015 Nov; 29(11):915-33. PubMed ID: 26519340
[TBL] [Abstract][Full Text] [Related]
12. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Sex Med; 2021 May; 18(5):849-867. PubMed ID: 33814355
[TBL] [Abstract][Full Text] [Related]
13. Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians.
Cocchetti C; Ristori J; Mazzoli F; Vignozzi L; Maggi M; Fisher AD
Int J Impot Res; 2020 Nov; 33(7):703-709. PubMed ID: 33558671
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
15. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Parish SJ; Hahn SR
Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
[TBL] [Abstract][Full Text] [Related]
16. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
17. Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
Simon JA; Clayton AH; Goldstein I; Kingsberg SA; Shapiro M; Patel S; Kim NN
Sex Med; 2022 Dec; 10(6):100570. PubMed ID: 36400683
[TBL] [Abstract][Full Text] [Related]
18. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
19. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA; Novick AM
J Midwifery Womens Health; 2021 Nov; 66(6):740-748. PubMed ID: 34510696
[TBL] [Abstract][Full Text] [Related]
20. Flibanserin for female sexual dysfunction.
Reviriego C
Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
